Tulavi Therapeutics
PrivateLast Round
Series C
Jul 15, 2025
Est. Valuation
$83M
Total Funding Raised
$34.34M
Company Overview
Tulavi Therapeutics is a medical devices & equipment company that develops absorbable hydrogel-based technologies to optimize nerve recovery and reduce the risk of neuroma formation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tulavi Therapeutics Comparables
Compare Tulavi Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Renerva, Inc. | 64% | |
| Alafair Biosciences, Inc. | 63% | |
| Stryker Corporation | 61% | |
Tulavi Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 15, 2025 | ||||
| Series B | Dec 16, 2021 | ||||
| Series A | Feb 27, 2021 | ||||
| Seed | May 8, 2020 | ||||
| Series A | Apr 26, 2018 |
Tulavi Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ascension Ventures | Seed, Series B, Series A |
| Greenwave Ventures | Series B, Series C |
| NeuroTechnology Investors | Series B |
| Delos Capital Partners | Seed, Series A |
| Medical Technology Enterprise Consortium | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 23, 2025
Partnered with Veterans Healthcare Supply Solutions for VA hospital distribution.
- Jul 15, 2025
$20M round led by Greenwave Ventures.
Tulavi Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tulavi Therapeutics's valuation, stock price, and market status.